CleanSpace was founded in 2009 by a team of biomedical engineers and following a successful testing and regulatory approval process launched its first respirator for use in industry in 2010. In 2013, CleanSpace entered the European market, followed by the US market in 2017. In 2018, CleanSpace launched its first healthcare respirator to a global market. In 2019, CleanSpace began business development for South East Asia.
CleanSpace develops and owns its proprietary technology. In the last 10 years, the Company has continued to invest in research and development programs resulting in differentiated design and approved products that provide compelling employer and user benefits, namely higher protection with improved compliance and productivity. CleanSpace technology incorporates miniaturisation (size and weight), smart pressure driven algorithms, intuitive function and unique neck mounted design, to achieve the highest level of protection
It is anticipated that CSX will list on the ASX during October 2020.
CleanSpace: Respiratory Protective Masks are a breath responsive, powered air purifying respirator that provide respiratory protection.